Carlsmed Inc. has announced the U.S. commercial launch of its aprevo® Technology Platform for cervical fusion surgeries, marking a significant expansion of its personalized spine surgery offerings. Building on the success of its lumbar platform, the new cervical system integrates AI-driven preoperative planning with 3D-printed, patient-specific implants tailored to individual anatomy and pathology. Early clinical experience from over 50 cases highlights enhanced implant fit, improved alignment, and efficient workflow integration. The launch was highlighted at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting, with leading surgeons presenting initial clinical data and feedback.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9595309-en) on December 03, 2025, and is solely responsible for the information contained therein.